- Lung cancer screening in the United States remains highly underused, with only 2% of eligible smokers undergoing low-dose CT (LDCT) in 2016.
Why this matters
- The US Preventive Services Task Force has recommended annual LDCT for lung cancer in high-risk patients since 2013.
- 7,613,000 people from the 2015 National Health Interview Survey Cancer Control Supplement who were eligible for lung cancer screening.
- Funding: Bristol-Myers Squibb Foundation.
- Only 2% of eligible smokers received LDCT for lung cancer in 2016.
- In 2016, the south had the largest number of smokers eligible for screening (40.4%), and the northeast had the lowest (15%).
- The west had the lowest screening rate (1.1%), followed by the south (1.7%), the Midwest (2.1%), and the northeast (3.9%).
- 84% of those screened were offered smoking cessation support.
- There were 1962 screening sites in 2016 in the United States that were accredited by the American College of Radiology.
- The south had the highest number of accredited facilities (n=728), followed by the Midwest (n=551), the northeast (n=441), and the west (n=242).
- Only American College of Radiology-accredited screening sites were included.